INTRODUCTION: Perivascular soft tissue tumors are relatively uncommon neoplasms of unclear line of differentiation, although most are presumed to originate from pericytes or modified perivascular cells. Among these, glomus tumor, myopericytoma, and angioleiomyoma share a spectrum of histologic findings and a perivascular growth pattern. In contrast, solitary fibrous tumor (previously termed hemangiopericytoma) was once hypothesized to have pericytic differentiation. METHODS: Here, we systematically examine pericyte immunohistochemical markers among glomus tumor (including malignant glomus tumor), myopericytoma, angioleiomyoma, and solitary fibrous tumor. Immunohistochemical staining and semiquantification was performed using well-defined pericyte antigens, including αSMA, CD146, and PDGFRβ. RESULTS: Glomus tumor and myopericytoma demonstrate diffuse staining for all pericyte markers, including immunohistochemical reactivity for αSMA, CD146, and PDGFRβ. Malignant glomus tumors all showed some degree of pericyte marker immunoreactivity, although it was significantly reduced. Angioleiomyoma shared a similar αSMA + CD146 + PDGFRβ+ immunophenotype; however, this was predominantly seen in the areas of perivascular tumor growth. Solitary fibrous tumors showed patchy PDGFRβ immunoreactivity only. DISCUSSION: In summary, pericyte marker expression is a ubiquitous finding in glomus tumor, myopericytoma, and angioleiomyoma. Malignant glomus tumor shows a comparative reduction in pericyte marker expression, which may represent partial loss of pericytic differentiation. Pericyte markers are essentially not seen in solitary fibrous tumor. The combination of αSMA, CD146, and PDGFRβ immunohistochemical stainings may be of utility for the evaluation of pericytic differentiation in soft tissue tumors.
INTRODUCTION: Perivascular soft tissue tumors are relatively uncommon neoplasms of unclear line of differentiation, although most are presumed to originate from pericytes or modified perivascular cells. Among these, glomus tumor, myopericytoma, and angioleiomyoma share a spectrum of histologic findings and a perivascular growth pattern. In contrast, solitary fibrous tumor (previously termed hemangiopericytoma) was once hypothesized to have pericytic differentiation. METHODS: Here, we systematically examine pericyte immunohistochemical markers among glomus tumor (including malignant glomus tumor), myopericytoma, angioleiomyoma, and solitary fibrous tumor. Immunohistochemical staining and semiquantification was performed using well-defined pericyte antigens, including αSMA, CD146, and PDGFRβ. RESULTS: Glomus tumor and myopericytoma demonstrate diffuse staining for all pericyte markers, including immunohistochemical reactivity for αSMA, CD146, and PDGFRβ. Malignant glomus tumors all showed some degree of pericyte marker immunoreactivity, although it was significantly reduced. Angioleiomyoma shared a similar αSMA + CD146 + PDGFRβ+ immunophenotype; however, this was predominantly seen in the areas of perivascular tumor growth. Solitary fibrous tumors showed patchy PDGFRβ immunoreactivity only. DISCUSSION: In summary, pericyte marker expression is a ubiquitous finding in glomus tumor, myopericytoma, and angioleiomyoma. Malignant glomus tumor shows a comparative reduction in pericyte marker expression, which may represent partial loss of pericytic differentiation. Pericyte markers are essentially not seen in solitary fibrous tumor. The combination of αSMA, CD146, and PDGFRβ immunohistochemical stainings may be of utility for the evaluation of pericytic differentiation in soft tissue tumors.
Authors: Lucio Díaz-Flores; Ricardo Gutiérrez; Maria P García; Hugo Alvarez-Argüelles; Lucio Díaz-Flores; Juan F Madrid Journal: J Cutan Pathol Date: 2011-11 Impact factor: 1.587
Authors: Juan-Miguel Mosquera; Andrea Sboner; Lei Zhang; Chun-Liang Chen; Yun-Shao Sung; Hsiao-Wei Chen; Narasimhan P Agaram; Daniel Briskin; Basma M Basha; Samuel Singer; Mark A Rubin; Thomas Tuschl; Cristina R Antonescu Journal: Genes Chromosomes Cancer Date: 2013-09-02 Impact factor: 5.006
Authors: Wei Tang; Daniel Zeve; Jae Myoung Suh; Darko Bosnakovski; Michael Kyba; Robert E Hammer; Michelle D Tallquist; Jonathan M Graff Journal: Science Date: 2008-09-18 Impact factor: 47.728
Authors: Swati Shrestha; Carolyn Meyers; Jia Shen; Paulina Giacomelli; Michelle A Scott; Chia Soo; Sarah M Dry; Kang Ting; Aaron W James Journal: J Orthop Date: 2016-12-27
Authors: Jia Shen; Swati Shrestha; Yu-Hsin Yen; Michelle A Scott; Greg Asatrian; Raymond Barnhill; Claire Lugassy; Chia Soo; Kang Ting; Bruno Peault; Sarah M Dry; Aaron W James Journal: Med Oncol Date: 2015-06-30 Impact factor: 3.064
Authors: Swati Shrestha; Jia Shen; Paulina Giacomelli; Michelle A Scott; Chia Soo; Kang Ting; Bruno Péault; Sarah M Dry; Aaron W James Journal: J Orthop Date: 2016-11-28
Authors: Jia Shen; Swati Shrestha; Yu-Hsin Yen; Michelle A Scott; Chia Soo; Kang Ting; Bruno Peault; Sarah M Dry; Aaron W James Journal: Hum Pathol Date: 2015-09-30 Impact factor: 3.466
Authors: Jia Shen; Swati Shrestha; P Nagesh Rao; Greg Asatrian; Michelle A Scott; Vi Nguyen; Paulina Giacomelli; Chia Soo; Kang Ting; Fritz C Eilber; Bruno Peault; Sarah M Dry; Aaron W James Journal: Hum Pathol Date: 2016-04-08 Impact factor: 3.466
Authors: Aaron W James; Paul Hindle; Iain R Murray; Christopher C West; Tulyapruek Tawonsawatruk; Jia Shen; Greg Asatrian; Xinli Zhang; Vi Nguyen; A Hamish Simpson; Kang Ting; Bruno Péault; Chia Soo Journal: Pharmacol Ther Date: 2016-08-07 Impact factor: 12.310